Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 19978

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.
Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.
In 2018, the global Gene Therapy for Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.

The key players covered in this study
Takara Bio
VBL Therapeutics
CELSION
Targovax
...

Market segment by Type, the product can be split into
Intravenous
Intratumoral
Intraperitoneal

Market segment by Application, split into
Ovarian Cancer (unspecified)
Recurrent Ovarian Epithelial Cancer
Platinum-Resistant Ovarian Cancer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy for Ovarian Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous
1.4.3 Intratumoral
1.4.4 Intraperitoneal
1.5 Market by Application
1.5.1 Global Gene Therapy for Ovarian Cancer Market Share by Application (2014-2025)
1.5.2 Ovarian Cancer (unspecified)
1.5.3 Recurrent Ovarian Epithelial Cancer
1.5.4 Platinum-Resistant Ovarian Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy for Ovarian Cancer Market Size
2.2 Gene Therapy for Ovarian Cancer Growth Trends by Regions
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions (2014-2025)
2.2.2 Gene Therapy for Ovarian Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy for Ovarian Cancer Market Size by Manufacturers
3.1.1 Global Gene Therapy for Ovarian Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
3.3 Key Players Gene Therapy for Ovarian Cancer Product/Solution/Service
3.4 Date of Enter into Gene Therapy for Ovarian Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019)
4.2 Global Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019)

5 United States
5.1 United States Gene Therapy for Ovarian Cancer Market Size (2014-2019)
5.2 Gene Therapy for Ovarian Cancer Key Players in United States
5.3 United States Gene Therapy for Ovarian Cancer Market Size by Type
5.4 United States Gene Therapy for Ovarian Cancer Market Size by Application

6 Europe
6.1 Europe Gene Therapy for Ovarian Cancer Market Size (2014-2019)
6.2 Gene Therapy for Ovarian Cancer Key Players in Europe
6.3 Europe Gene Therapy for Ovarian Cancer Market Size by Type
6.4 Europe Gene Therapy for Ovarian Cancer Market Size by Application

7 China
7.1 China Gene Therapy for Ovarian Cancer Market Size (2014-2019)
7.2 Gene Therapy for Ovarian Cancer Key Players in China
7.3 China Gene Therapy for Ovarian Cancer Market Size by Type
7.4 China Gene Therapy for Ovarian Cancer Market Size by Application

8 Japan
8.1 Japan Gene Therapy for Ovarian Cancer Market Size (2014-2019)
8.2 Gene Therapy for Ovarian Cancer Key Players in Japan
8.3 Japan Gene Therapy for Ovarian Cancer Market Size by Type
8.4 Japan Gene Therapy for Ovarian Cancer Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy for Ovarian Cancer Market Size (2014-2019)
9.2 Gene Therapy for Ovarian Cancer Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type
9.4 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application

10 India
10.1 India Gene Therapy for Ovarian Cancer Market Size (2014-2019)
10.2 Gene Therapy for Ovarian Cancer Key Players in India
10.3 India Gene Therapy for Ovarian Cancer Market Size by Type
10.4 India Gene Therapy for Ovarian Cancer Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy for Ovarian Cancer Market Size (2014-2019)
11.2 Gene Therapy for Ovarian Cancer Key Players in Central & South America
11.3 Central & South America Gene Therapy for Ovarian Cancer Market Size by Type
11.4 Central & South America Gene Therapy for Ovarian Cancer Market Size by Application

12 International Players Profiles
12.1 Takara Bio
12.1.1 Takara Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy for Ovarian Cancer Introduction
12.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.1.5 Takara Bio Recent Development
12.2 VBL Therapeutics
12.2.1 VBL Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy for Ovarian Cancer Introduction
12.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.2.5 VBL Therapeutics Recent Development
12.3 CELSION
12.3.1 CELSION Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy for Ovarian Cancer Introduction
12.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.3.5 CELSION Recent Development
12.4 Targovax
12.4.1 Targovax Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy for Ovarian Cancer Introduction
12.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.4.5 Targovax Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details